Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells.
Withers DR, Hepworth MR, Wang X, Mackley EC, Halford EE, Dutton EE, Marriott CL, Brucklacher-Waldert V, Veldhoen M, Kelsen J, Baldassano RN, Sonnenberg GF. Withers DR, et al. Among authors: brucklacher waldert v. Nat Med. 2016 Mar;22(3):319-23. doi: 10.1038/nm.4046. Epub 2016 Feb 15. Nat Med. 2016. PMID: 26878233 Free PMC article.
Dietary influences on intestinal immunity.
Veldhoen M, Brucklacher-Waldert V. Veldhoen M, et al. Among authors: brucklacher waldert v. Nat Rev Immunol. 2012 Oct;12(10):696-708. doi: 10.1038/nri3299. Nat Rev Immunol. 2012. PMID: 23007570 Review.
Cellular Plasticity of CD4+ T Cells in the Intestine.
Brucklacher-Waldert V, Carr EJ, Linterman MA, Veldhoen M. Brucklacher-Waldert V, et al. Front Immunol. 2014 Oct 7;5:488. doi: 10.3389/fimmu.2014.00488. eCollection 2014. Front Immunol. 2014. PMID: 25339956 Free PMC article. Review.
Degradation of IKZF1 prevents epigenetic progression of T cell exhaustion in an antigen-specific assay.
Tay T, Bommakanti G, Jaensch E, Gorthi A, Karapa Reddy I, Hu Y, Zhang R, Doshi AS, Tan SL, Brucklacher-Waldert V, Prickett L, Kurasawa J, Overstreet MG, Criscione S, Buenrostro JD, Mele DA. Tay T, et al. Among authors: brucklacher waldert v. Cell Rep Med. 2024 Nov 19;5(11):101804. doi: 10.1016/j.xcrm.2024.101804. Epub 2024 Oct 31. Cell Rep Med. 2024. PMID: 39486420 Free PMC article.
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors.
Archer S, Brailey PM, Song M, Bartlett PD, Figueiredo I, Gurel B, Guo C, Brucklacher-Waldert V, Thompson HL, Akinwale J, Boyle SE, Rossant C, Birkett NR, Pizzey J, Maginn M, Legg J, Williams R, Johnston CM, Bland-Ward P, de Bono JS, Pierce AJ. Archer S, et al. Among authors: brucklacher waldert v. Clin Cancer Res. 2024 Apr 15;30(8):1595-1606. doi: 10.1158/1078-0432.CCR-23-3052. Clin Cancer Res. 2024. PMID: 38593226 Free PMC article.
11 results